| Immunogenicity of COVID-19 Vaccine on Heterologous Schedule (NCT05054621) | Chang Gung Memorial Hospital | 2021-09-15 |
| Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Prospective Cohort Study (NCT05115617) | Ottawa Hospital Research Institute | 2021-06-03 |
| Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies (NCT04878822) | Ospedale di Circolo - Fondazione Macchi | 2021-04-13 |
| Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial (NCT04961385) | Bangkok Metropolitan Administration Medical College and Vajira Hospital | 2021-04-01 |
| Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines (NCT05150834) | Korea University Guro Hospital | 2021-02-25 |
| COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS (NCT04754698) | University of Sao Paulo General Hospital | 2021-02-09 |
| Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30 (NCT06778304) | West China Second University Hospital | 2021-01-04 |
| Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III) (NCT04051268) | PT Bio Farma | 2020-03-02 |
| Protectivity and Safety Following Recombinant Hepatitis B Vaccine (NCT03919578) | PT Bio Farma | 2019-09-11 |
| EMaBS TB Vaccine Study (NCT03681860) | University of Oxford | 2019-07-01 |
| Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects. (NCT04015232) | Intas Pharmaceuticals, Ltd. | 2018-02-26 |
| Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children (NCT03680417) | PT Bio Farma | 2017-11-16 |
| Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa (NCT03722615) | University of Witwatersrand, South Africa | 2016-05-06 |
| A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique (NCT01697007) | Muhimbili University of Health and Allied Sciences | 2012-11-01 |
| Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants (NCT01763268) | Queen Sirikit National Institute of Child Health | 2012-09-01 |
| A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants (NCT01399853) | Jiangsu Province Centers for Disease Control and Prevention | 2011-07-01 |
| Shigella Sonnel O-SPC/rBRU Conjugate Vaccine (NCT01369927) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2011-05-15 |
| Gardasil Vaccination in Post Stem Cell Transplant Patients (NCT01092195) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-06-02 |